Gender differences in hypertrophic cardiomyopathy assessed by cardiovascular magnetic resonance feature tracking

Back

Open Access

Gender differences in hypertrophic cardiomyopathy assessed by cardiovascular magnetic resonance feature tracking

Session: Hypertrophic cardiomyopathy: diagnosis and management

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor R. Tomoaia (Leeds, GB)

Event: ESC Preventive Cardiology 2024

Congress Presentation

About the speaker

Doctor Raluca Tomoaia

Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

10 more presentations in this session

Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy

Speaker: Doctor C. Nie (Beijing, CN)

Access

Abstract

Slides

Are patients with hypertrophic cardiomyopathy given appropriate advice on exercise at a central London inherited cardiac conditions outpatient service?

Speaker: Doctor K. Sonthikaew (London, GB)

Access

Abstract

Slides

Cardiac magnetic resonance imaging aids in differentiating dilated cardiomyopathy from the athlete's heart

Speaker: Mr J. Daems (Utrecht, NL)

Access

Abstract

Slides

Optimising screening of intermediate to high-risk asymptomatic sportsmen with exercise electrocardiogram.

Speaker: Doctor D. Hupin (Saint-Etienne, FR)

Access

Abstract

Slides

Cardiopulmonary exercise testing in athletes and non-athletes with hypertrophic cardiomyopathy

Speaker: Doctor J. Scicluna (Msida, MT)

Access

Abstract

Slides

Access the full session

Hypertrophic cardiomyopathy: diagnosis and management

Speakers: Doctor R. Tomoaia, Doctor C. Nie, Doctor K. Sonthikaew, Mr J. Daems, Doctor D. Hupin...

Access

About the event

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources